Transparency Market Research

About Us   Services   Career   FAQs   Contact Us

USA - Canada Toll Free 866-552-3453  

Home Pharmaceutical Neuromodulation Devices Market - Global Industry Size, Market Share, Trends, Analysis, And Forecast, 2012 - 2018

Neuromodulation Devices Market - Global Industry Size, Market Share, Trends, Analysis, And Forecast, 2012 - 2018

125pages
Published Date: 2012-10-30
 

Description




Description

This report covers an in depth analysis of the neuromodulation devices market across the globe. A detailed analysis of the market size in terms of annual revenue in USD millions is provided for the period 2012 to 2018, keeping 2011 as a base year. The neuromodulation devices market is segmented on the basis of technology into: Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Vagus Nerve Stimulation Devices, Sacral Nerve Stimulation Devices and Gastric Electric Stimulation Devices.

The neuromodulation devices market is also segmented on the basis of different application areas into: Medtronic’s Spinal Cord and Deep Brain Neurostimulation Systems, St. Jude Medical’s Eon Mini Neurostimulator System, Boston Scientific’s Precision Spinal Cord Stimulation System, Nevro’s Senza System for Spinal Cord Stimulation, Cyberonics’ VNS Therapy System, Codman & Shurtleff’s Medstream system, Medtronic’s Enterra Therapy System and IntraPace’s abiliti system. The market analysis for all these segments is provided on a geographical level and this report covers four major geographies namely: North America, Europe, Asia Pacific and the rest of the world.


In this research report Transparency Market Research covers an in depth competitive analysis for the market, taking into consideration some of the major market players. The market players considered are: Medtronic, St. Jude Medical, Boston Scientific Group, Cyberonics, Nevro, Codman and Shurtleff, Integra, IntraPace, Neuronetics Inc., Cervel Neurotech Inc. and Uroplasty. A detailed analysis of their business strategies, company overview, financial overview, product portfolio SWOT Analysis and recent developments is also provided in the report.

We have used secondary research for deriving our market numbers for each segment of the research report and further validated our analysis with C-level executives of major companies operating in the neuromodulation devices market through means of primary research to finally come up with our results. This research is specially designed to estimate and analyze the performance of neuromodulation devices in a global scenario. This research provides in-depth analysis of the neuromodulation devices market sales, trend analysis by segments and demand by geography. The study presents a comprehensive assessment of the stakeholder strategies and winning imperatives for them by segmenting the global neuromodulation devices market as below:

Neuromodulation Devices Market by Technology

  • Spinal Cord Stimulation Devices
  • Deep Brain Stimulation Devices
  • Vagus Nerve Stimulation Devices
  • Sacral Nerve Stimulation Devices
  • Gastric Electric Stimulation Devices
Neuromodulation Systems for Different Application Areas 

  • Medtronic’s Spinal Cord and Deep Brain Neurostimulation Systems
  • St. Jude Medical’s Eon  Mini Neurostimulator System
  • Boston Scientific’s Precision Spinal Cord Stimulation System
  • Nevro’s Senza System for Spinal Cord Stimulation
  • Cyberonics’ VNS Therapy System
  • Codman & Shurtleff’s Medstream system
  • Medtronic’s Enterra™ Therapy System
  • IntraPace’s abiliti system

Neuromodulation Devices Market by Geography

  • North America
  • Europe
  • Asia Pacific
  • RoW (Rest of the World)

Table of Contents




TABLE OF CONTENTS

1. Preface
    1.1. Report Description
    1.2. Research Methodology

2. Executive Summary and Market Overview

3. Neuromodulation Devices Market Analysis
    3.1. Market Trends and Future Outlook
    3.2. Market Share
    3.3. Growth Drivers
           3.3.1. Aging population inducing chronic diseases such as Parkinson’s  and Alzheimer’s
           3.3.2. Technological advancements 
           3.3.3. Rising prevalence of chronic diseases and the presence of unmet medical needs
           3.3.4. Add on therapy nature of the Neuromodulation devices
           3.3.5. Increasing demand for minimally invasive surgeries 
           3.3.6. Rising healthcare related consumer expenditure
           3.3.7. External funding to conduct clinical studies
    3.4. Neuromodulation Devices Drivers Impact Analysis
    3.5. Restraints
           3.5.1. Side effects and risks of Neuromodulation
           3.5.2. FDA approvals and other government regulations
           3.5.3. Rapidly changing technologies
           3.5.4. Affordable Healthcare for America Act, 2010
           3.5.5. Availability of alternate treatment procedures
    3.6. Neuromodulation Devices Restraints Impact Analysis
    3.7. Opportunities
           3.7.1. Emerging economies in Asia, Latin America and Eastern European countries
           3.7.2. Medical device manufacture outsourcing
           3.7.3. Investments in R&D and clinical studies
           3.7.4. Consolidation in healthcare industry
    3.8. Opportunity Impact Analysis for the Neuromodulation Devices Market
    3.9. Porter’s Five Forces Model for the Neuromodulation Devices Market

4. Neuromodulation Devices Market by Technology
    4.1. Spinal Cord Stimulation Devices
           4.1.1. Overview
           4.1.2. Market Estimate and Forecast
    4.2. Deep Brain Stimulation Devices
           4.2.1. Overview
           4.2.2. Market Estimate and Forecast
    4.3. Vagus Nerve Stimulation Devices
           4.3.1. Overview
           4.3.2. Market Estimate and Forecast
    4.4. Sacral Nerve Stimulation Devices
           4.4.1. Overview
           4.4.2. Market Estimate and Forecast
    4.5. Gastric Electric Stimulation Devices
           4.5.1. Overview
           4.5.2. Market Estimate and Forecast

5. Neuromodulation Systems for Different Application Areas
    5.1. Medtronic’s Spinal Cord and Deep Brain Neurostimulation Systems
           5.1.1. Application Overview
           5.1.2. Market Estimate and Forecast
    5.2. St. Jude Medical’s Eon  Mini Neurostimulator System
           5.2.1. Application Overview
           5.2.2. Market Estimate and Forecast
    5.3. Boston Scientific’s Precision Spinal Cord Stimulation System
           5.3.1. Application Overview
           5.3.2. Market Estimate and Forecast
    5.4. Nevro’s Senza System for Spinal Cord Stimulation
           5.4.1. Application Overview
           5.4.2. Market Estimate and Forecast
    5.5. Cyberonics’ VNS Therapy System
           5.5.1. Application Overview
           5.5.2. Market Estimate and Forecast
    5.6. Codman & Shurtleff’s Medstream system
           5.6.1. Application Overview
           5.6.2. Market Estimate and Forecast
    5.7. Medtronic’s Enterra™ Therapy System
           5.7.1. Application Overview
           5.7.2. Market Estimate and Forecast
    5.8. IntraPace’s abiliti system
           5.8.1. Application Overview
           5.8.2. Market Estimate and Forecast

6. Neuromodulation Devices Market by Geography
    6.1. North America
           6.1.1. Overview
           6.1.2. Market Estimate and Forecast
    6.2. Europe
           6.2.1. Overview
           6.2.2. Market Estimate and Forecast
    6.3. Asia Pacific
           6.3.1. Overview
           6.3.2. Market Estimate and Forecast
    6.4. Rest of the World
           6.4.1. Overview
           6.4.2. Market Estimate and Forecast

7. Competitive Landscape
    7.1. Summary 
    7.2. Market share by Key Players
    7.3. New Entrants/Market Players
    7.4. Competitive strategy by Key Players
           7.4.1. Market Leaders
           7.4.2. New Entrants
    7.5. Recent Developments

8. Recommendations
    8.1. Market Strategy for Success
    8.2. Barriers to be Considered
    8.3. Future Assumptions

9. Company Profiles
    9.1. Existent Players
           9.1.1. Medtronic
                     9.1.1.1. Company Overview
                     9.1.1.2. Business Strategies
                     9.1.1.3. Financial Overview
                     9.1.1.4. Product Portfolio
                     9.1.1.5. SWOT Analysis
                     9.1.1.6. Recent Developments
           9.1.2. St. Jude Medical
                     9.1.2.1. Company Overview
                     9.1.2.2. Business Strategies
                     9.1.2.3. Financial Overview
                     9.1.2.4. Product Portfolio
                     9.1.2.5. SWOT Analysis
                     9.1.2.6. Recent Developments
            9.1.3. Boston Scientific
                     9.1.3.1. Company Overview
                     9.1.3.2. Business Strategies
                     9.1.3.3. Financial Overview
                     9.1.3.4. Product Portfolio
                     9.1.3.5. SWOT Analysis
                     9.1.3.6. Recent Developments
           9.1.4. Cyberonics
                     9.1.4.1. Company Overview
                     9.1.4.2. Business Strategies
                     9.1.4.3. Financial Overview
                     9.1.4.4. Product Portfolio
                     9.1.4.5. SWOT Analysis
                     9.1.4.6. Recent Developments
            9.1.5. Nevro
                     9.1.5.1. Company Overview
                     9.1.5.2. Business Strategies
                     9.1.5.3. Financial Overview
                     9.1.5.4. Product Portfolio
                     9.1.5.5. Recent Developments
    9.2. New Entrants
           9.2.1. Johnson & Johnson (Codman and Shurtleff)
                     9.2.1.1. Company Overview
                     9.2.1.2. Business Strategies
                     9.2.1.3. Financial Overview
                     9.2.1.4. Product Portfolio
                     9.2.1.5. SWOT Analysis
                     9.2.1.6. Recent Developments
            9.2.2. Integra
                     9.2.2.1. Company Overview
                     9.2.2.2. Business Strategies
                     9.2.2.3. Financial Overview
                     9.2.2.4. Product Portfolio
                     9.2.2.5. Recent Developments
            9.2.3. IntraPace
                     9.2.3.1. Company Overview
                     9.2.3.2. Business Strategies
                     9.2.3.3. Financial Overview
                     9.2.3.4. Product Portfolio
                     9.2.3.5. Recent Developments
            9.2.4. Neuronetics, Inc.
                     9.2.4.1. Company Overview
                     9.2.4.2. Business Strategies
                     9.2.4.3. Financial Overview
                     9.2.4.4. Product Portfolio
                     9.2.4.5. Recent Developments
           9.2.5. Cervel Neurotech, Inc.
                     9.2.5.1. Company Overview
                     9.2.5.2. Business Strategies
                     9.2.5.3. Financial Overview
                     9.2.5.4. Product Portfolio
                     9.2.5.5. Recent Developments
           9.2.6. Uroplasty
                     9.2.6.1. Company Overview
                     9.2.6.2. Business Strategies
                     9.2.6.3. Financial Overview
                     9.2.6.4. Product Portfolio
                     9.2.6.5. Recent Developments

Market Overview





Neuromodulation is one of the fastest growing sectors in the medical devices market. Neuromodulation devices provide symptomatic relief through alteration, or modulation of nerve system function. Neuromodulation functions either by stimulating nerves to produce a natural biological response or by applying small doses of medicines directly to the site of action. The neuromodulation devices market is growing rapidly due to increase in the ageing population resulting in increased demand for newer treatment options for age related diseases. 

This market is expected to benefit from the rise in demand for non-invasive treatment options. Advancement in technology and increased knowledge in neurophysiology offers vast potential opportunities in treatment, influencing stupendous growth of the neuromodulation devices market. Neuromodulation market addresses the huge patient population in epilepsy, anxiety disorders, stroke, depression, Parkinson’s disease, and others. With this stupendous growth, neuromodulation market is expected to become as large as the cardiac devices market.
 
Market Segmentation
  • Deep Brain Stimulation (DBS)
  • Transcranial Magnetic Stimulation (TMS)
  • Spinal Cord Stimulation (SCS)
  • Vagus Nerve Stimulation (VNS)
  • Peripheral Stimulation
This research report analyzes this market based on its market segments and major geographies. It includes a comprehensive study of the ongoing market trends, industry growth drivers, restraints, market structure, and market projections for the coming years. The report also includes an analysis of the technological developments in the neuromodulation devices market, Porter’s five force model analysis, and company profiles of the top industry players. It provides a review of the micro and macro factors significant from the point of view of the existing market players and new entrants with value chain analysis. 

Major geographies analyzed under this report are North America, Europe, Asia-Pacific, and the Rest of the World.

Some of the major players dominating the market of neuromodulation devices are Medtronic, St. Jude Medical, Boston Scientific, Cyberonics, IntraPace, Nevro, Johnson & Johnson, Codman, Integra, and others. 

Enquiry Before Buying




 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research